VFM-100 contains the flavonoid called glabridin, a dietary ingredient which functions to decrease body fat including the visceral fat that is the main cause of Metabolic Syndrome. Glabridin is the result of over a decade of research and
development, culminating in the acceptance of glabridin as a New Dietary Ingredient (NDI) by the Food and Drug Administration.
Glabridin is isolated from the roots of Glycyrrhiza glabra L., a plant with thousands of years of safe and effective use. Glabridin is a potent antioxidant phytochemical and chemically, glabridin is known as a flavonoid molecule that is part of a larger family of plant-derived polyphenols. Both animal research and two
controlled human clinical studies have demonstrated the reliability of glabridin as a safe and effective approach to inhibit the accumulation of excess body fat, especially visceral fat. Reduction of abdominal fat and a reduction of metabolic risk factors can be achieved through the use VFM-100 which specifically targets the adipose tissue that surrounds the viscera.
Clinically it is known that abdominal visceral obesity is of particular concern since it further contributes to the progression of Metabolic Syndrome with its poorly controlled levels of blood sugar and dysinsulinemia leading to increased weight gain, elevated blood pressure, and abnormal blood lipid profiles.
Human clinical studies have documented that glabridin reduces body weight, decrease waist circumference and mobilizes visceral fat while acting to regulate and maintain healthy blood sugar levels. Research conducted in two different strains of laboratory mice, used as models of human diabetes and obesity, has shown that glabridin reduced the accumulation of visceral fat and down regulated the fat forming enzymes in the abdominal adipose tissue; in addition, glabridin stimulated the activity of mitochondrial beta-oxidation or ‘fat burning’ enzymes in the liver. The placebo-controlled, double-blind human studies have confirmed and extended the results of the experiments
performed in the mouse models. Glabridin reduced the amounts of visceral fat, as confirmed by sophisticated dual-energy X-ray absorptiometry (DXA) scans and produced reductions of body weight gain and decreased body fat. In combination with a healthy diet and moderate daily exercise, VFM-100 helps to
maintain optimal body weight and promotes healthy fat metabolism, eliminating the consequences of visceral fat accumulation and the morbidity associated with Metabolic Syndrome.
• Abdominal Visceral Obesity--defined as a Waist Circumference
over 40 inches in Males, and over 35 inches in Females OR a
Waist-Hip ratio of >0.9 for Males, and >0.85 for Females
• Metabolic Syndrome or Syndrome X
• Cardiometabolic Risk Factors.
SERVING SIZE: 3 Softgel Capsules
SERVINGS PER CONTAINER: 30
AMOUNT PER SERVING:
Calories from fat 5
Fat 0.5 g
Licorice Flavonoid Oil 300 mg
(Kaneka Glavonoid standardized to 30% polyphenols
and 3% glabridin)
Medium chain triglycerides (containing trace amounts of soy-derived mixed tocopherols), modified food starch, vegetable glycerol, beeswax, carrageenan and disodium phosphate.
Kaneka Glavonoid is a trademark of Kaneka Corporation.
Take 3 softgels daily with the evening meal.
None known at the recommended dosage.
|***SPEND $75 OR MORE AFTER COUPONS AND DISCOUNTS AND REGULAR SHIPPING IS FREE!|
Thank you for visiting our store. We strive to meet your needs and if there is anything we can do to make this a more effective experience, please let us know. We are committed to providing the absolute best quality products along with the best in customer service.